Edesa Biotech, Inc.
EDSA
$5.11
-$0.26-4.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -165.24% | -38.98% | -131.62% | -4.87% | 14.55% |
| Total Depreciation and Amortization | 5.71% | -40.84% | -41.40% | -49.81% | -46.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 626.99% | 392.49% | 330.67% | 62.01% | -50.56% |
| Change in Net Operating Assets | 291.29% | -995.04% | 153.88% | -123.74% | -4,350.00% |
| Cash from Operations | 15.39% | -37.58% | -77.97% | -98.58% | -43.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 458.04% | -- | -100.00% | 2,391.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.94% | -48.33% | -8.28% | 100.00% | -1,168.12% |
| Cash from Financing | -100.06% | 61.98% | 693.95% | -100.00% | 6,878.22% |
| Foreign Exchange rate Adjustments | 60.11% | 69.86% | -586.27% | 2,097.59% | -186.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.61% | 139.38% | -56.39% | -102.32% | 940.01% |